Pyridoxine-related metabolite concentrations in normal and down syndrome amniotic fluid

Fetal Diagnosis and Therapy

Volumn 23, Issue 4, 2008, Pages 254-257

  Baggot, Paddy Jim ^a,b,e   Eliseo, Anna Jane Y ^b   DeNicola, Nathaniel G ^b   Kalamarides, Jeremy A ^c   Shoemaker, James D ^d  

^a Hollywood Presbyterian Medical Center   (United States)

^b Santa Teresita Medical Center   (United States)

^c LAKE ERIE COLLEGE OF OSTEOPATHIC MEDICINE   (United States)

^d SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e NONE   (United States)

Author keywords

Amniotic fluid; Down syndrome; Oxalate; Pyridoxine

Indexed keywords

KYNURENINE; OXALIC ACID; PYRIDOXIC ACID; PYRIDOXINE; XANTHURENIC ACID;

AMNION FLUID; ARTICLE; DISEASE MARKER; DOWN SYNDROME; DRUG METABOLISM; FETUS; HUMAN; MASS FRAGMENTOGRAPHY; METABOLITE; PRIORITY JOURNAL; PYRIDOXINE DEFICIENCY; QUANTITATIVE ANALYSIS; STATISTICAL SIGNIFICANCE;

AMNIOTIC FLUID; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; DOWN SYNDROME; FEMALE; HUMANS; KYNURENINE; OXALIC ACID; PREGNANCY; PRENATAL DIAGNOSIS; PYRIDOXIC ACID; PYRIDOXINE; RETROSPECTIVE STUDIES; XANTHURENATES;

EID: 42449084590     PISSN: 10153837     EISSN: None     Source Type: Journal    
DOI: 10.1159/000123610     Document Type: Article

References (11)

1. Pueschel SM: Biomedical aspects of Down syndrome: biochemistry; Pueschel SM, Rynders JE (eds): Down Syndrome: Advances in Biomedicine and the Behavioral Sciences. Cambridge, Ware Press, 1982, pp 249-268.
2. Coburn SP, Seidenberg M: Leukocyte pyridoxal phosphate and alkaline phosphatase in Down syndrome and other retardates. Am J Clin Nutr 1969;22:1197-1203.
3. Pueschel SM, Reed RB, Cronk CE, Goldstein BI: 5-Hydroxytryptophan and pyridoxine. Am J Dis Child 1980;134:838-844.
4. Coleman M: Infantile spasms associated with 5-hydroxytryptophan administration in patients with Down syndrome. Neurology 1971;21:911-919.
5. 6 in Down's syndrome infants. Part 2. Cortical auditory evoked potentials. J Ment Defic Res 1985;29:241-246.
6. 6 in Down's syndrome infants. Part 1. Clinical and biochemical results. J Ment Defic Res 1985;29:233-240.
7. 6 in Down syndrome. Ann NY Acad Sci 1969;166:116-125.
8. Shoemaker JD, Elliott WH: Automated screening of urine samples for carbohydrate, organic and amino acids after treatment with urease. J Chromatogr Biomed App 1991;562:125-138.
9. Nath R, Thind SK, Murthy MSR, Farooqui S, Gupta R, Koul HK: Role of pyridoxine in oxalate metabolism. Ann NY Acad Sci 1990;585:274-284.
10. Curhan GC, Willett WC, Speizer FE, Stampfer MJ: Intake of vitamins B6 and C and the risk of kidney stones in women. J Am Soc Nephrol 1999;10:840-845.
11. Gershoff SN, Prien EL: Effect of daily MgO and vitamin B6 administration to patients with recurring calcium oxalate kidney stones. Am J Clin Nutr 1967;20:393-399.